Manufacturing Technologies

Home

Innovations

We Are Passionate About Saving Lives With Pioneering Proven Diagnostic

Cellex has met the Quality standard

Cellex acquired ISO13485, GMP, and ANVISA and is striving to provide the best products
with a thorough and systematic quality management system.

ISO13485
GMP
ANVISA

Cellex-Globally Licensed
Sold in 90 Countries

With operations inOver 90 Countries,
A Strategically Established Global Presence.

Cellex breaks ground on new global Biomedical Research center in San Diego

Founder James Li and the Cellex team had already created a lineage of more than 50 pioneering diagnostic test successes on multiple platforms (drug resistance, UTI, TB, MI and others) when the COVID-19 outbreak began. They realized that their technologies could help save lives if they moved quickly to bring multiple COVID-19 tests to commercial readiness.

Learn More About Our Sites

View

Cellex global production and R&D

2002

Founded in 2002, Cellex Incorporated is a biotech company that develops technologies

~ 6 years

Reduced first human dose to medicine launch from ~11years to ~6years.

Medicines launched globally in a single decade, including game-changing therapies for diabetes, obesity and Alzheimer’s disease.

Bringing research, development, and manufacturing closer to patients and communities in the US strategically enables our journey toward becoming a top player in the US market and reflects our long-term commitment to patients and a future-ready supply chain.

Victor Bultó, US President, Novartis